Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-02 @ 9:58 AM
Study NCT ID:
NCT00066469
Status:
COMPLETED
Last Update Posted:
2019-08-06
First Post:
2003-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
Sponsor:
Children's Oncology Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
ANHL0221
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |